We also invest in for-profit ventures that show potential to improve human well-being at scale.
Our goal is to improve the lives of others as much as we can. While our focus is grantmaking, what matters most to us is an organization’s potential for impact — not its tax status.
Good Ventures LLC, at the recommendation of the Open Philanthropy Project, invested $4.7 million in VasoRx, a startup developing a new therapy for vascular diseases such as atherosclerosis that are among the leading causes of death in the developed world.
In February 2018, Good Ventures LLC invested $14 million in the Dementia Discovery Fund, a venture capital fund investing in novel science to create new medicines for dementia, which affects more than 47 million people worldwide.
In August 2012, Good Ventures LLC led a $15M Series A round of investment in Vicarious FPC, an artificial intelligence company which uses the computational principles of the brain to build software that can think and learn like a human.